Predictor of Postoperative Complications After Lengthy Noncardiac Surgery (complication)

January 21, 2025 updated by: Amr Samir Wahdan, Cairo University

Peripheral Perfusion Index Versus Serum Lactate Levels as Predictor of Postoperative Complications and Prolonged ICU Stay After Lengthy Surgical Procedures: a Prospective Observational Study

Many patients undergoing long time surgery will manifest increased level of blood lactate.

Hyperlactacidemia can cause disturbance of internal environment, then leading to increased complications and longer ICU stay, even death. For postoperative patients, we must ensure adequate perfusion in order to minimize the length of hyperglycemia and improve patients' outcomes. With regard to lactate, it provides information about prefusion, but not timely enough for its delay on reflecting hypoperfusion. And it's not real-time and non-invasive.

Peripheral perfusion index (PPI) is an indicator reflecting hypoperfusion in critical patients. It is measured using pulse co-oximetry technology which is characterized by being real-time and noninvasive. PPI is defined as "the ratio of pulsatile blood flow to the non-pulsatile blood flow", mirroring the strength of blood flow and quality of perfusion at sensor site, reflecting perfusion state of the body part . In contrast to lactate value, it's real-time and easy to monitor.

Study Overview

Study Type

Observational

Enrollment (Actual)

235

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt, 11451
        • Cairo University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

This study will be designed to recruit patients scheduled for elective surgery with duration > 120 minutes under general anaesthesia

Description

  • Inclusion criteria
  • Adult patients above 18 years of age.
  • Both genders
  • surgical time planned to be > 120 minutes .
  • surgical time predicted to exceed the planned time and prolongation of surgical time > 120 minutes occured will be included in the study .
  • ASA physical status of I-II
  • Patients scheduled for elective surgery under general anaesthesia .
  • Exclusion criteria
  • Refused to participate .
  • patient with disease affecting blood flow to the hands where probe will be applied .
  • patient with hand injuries so probe cannot be applied
  • Patient with sever renal and liver disease
  • Discharging against medical advice or reported death during ICU stay at first 48 hours after ICU admission .
  • Pregnancy or emergency surgery .
  • shortening of the planned surgical time to be less than 120 minutes

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Non complications group
where the non-complicated patients is the patients running the normal postoperative course of surgery and without any need for intervention
Peripheral Perfusion index is the ratio between pulsatile blood flow to non pulsatile blood flow or static blood in the peripheral tissue
Blood lactate (product of metabolism) level is maintained by a cycle of continuous production and metabolism allowing it to be kept within normal values
complications group
any deviation from the normal post-operative course
Peripheral Perfusion index is the ratio between pulsatile blood flow to non pulsatile blood flow or static blood in the peripheral tissue
Blood lactate (product of metabolism) level is maintained by a cycle of continuous production and metabolism allowing it to be kept within normal values

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Peripheral perfusion index
Time Frame: up to 48 hours
at end of surgery as early predictor of postoperative complications .
up to 48 hours
serum lactate level
Time Frame: up do 48 hours
at end of surgery as early predictor of postoperative complications .
up do 48 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Peripheral perfusion index
Time Frame: UP TO 30 DAY
at end of surgery as predictor seversity of postoperative complications .
UP TO 30 DAY
serum lactate level
Time Frame: UP TO 30 day
at end of surgery as early predictor of postoperative complications .
UP TO 30 day
Postoperative complications
Time Frame: up to 30 day
the Clavien-Dindo classification system Grade I complications Grade II complications Grade III complications Grade IV complications
up to 30 day
hemodynamic change
Time Frame: up do 48 hours
mean arterial blood pressure
up do 48 hours
heart rate
Time Frame: up do 48 hours
hemodynamic change
up do 48 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Amr s wahdan, MD, Cairo university , Cairo, Egypt

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 15, 2021

Primary Completion (Actual)

May 12, 2024

Study Completion (Actual)

June 10, 2024

Study Registration Dates

First Submitted

December 18, 2020

First Submitted That Met QC Criteria

December 18, 2020

First Posted (Actual)

December 23, 2020

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 21, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • MS-390-2020

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Peripheral Perfusion Index

Clinical Trials on Peripheral Perfusion index

Subscribe